Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans

被引:239
作者
Sandbulte, Matthew R.
Jimenez, Gretchen S.
Boon, Adrianus C. M.
Smith, Larry R.
Treanor, John J.
Webby, Richard J.
机构
[1] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA
[2] Vical, San Diego, CA USA
[3] Univ Rochester, Infect Dis Unit, Rochester, NY 14627 USA
关键词
D O I
10.1371/journal.pmed.0040059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: A pandemic H5N1 influenza outbreak would be facilitated by an absence of immunity to the avian-derived virus in the human population. Although this condition is likely in regard to hemagglutinin-mediated immunity, the neuraminidase (NA) of H5N1 viruses (avN1) and of endemic human H1N1 viruses (huN1) are classified in the same serotype. We hypothesized that an immune response to huN1 could mediate cross-protection against H5N1 influenza virus infection. Methods and Findings: Mice were immunized against the NA of a contemporary human H1N1 strain by DNA vaccination. They were challenged with recombinant A/Puerto Rico/8/34 (PR8) viruses bearing huN1 (PR8-huN1) or avN1 (PR8-avN1) or with H5N1 virus A/Vietnam/1203/04. Additional naïve mice were injected with sera from vaccinated mice prior to H5N1 challenge. Also, serum specimens from humans were analyzed for reactivity with avN1. Immunization elicited a serum IgG response to huN1 and robust protection against the homologous challenge virus. Immunized mice were partially protected from lethal challenge with H5N1 virus or recombinant PR8-avN1. Sera transferred from immunized mice to naïve animals conferred similar protection against H5N1 mortality. Analysis of human sera showed that antibodies able to inhibit the sialidase activity of avN1 exist in some individuals. Conclusions: These data reveal that humoral immunity elicited by huN1 can partially protect against H5N1 infection in a mammalian host. Our results suggest that a portion of the human population could have some degree of resistance to H5N1 influenza, with the possibility that this could be induced or enhanced through immunization with seasonal influenza vaccines. © 2007 Sandbulte et al.
引用
收藏
页码:265 / 272
页数:8
相关论文
共 20 条
[1]  
Wong S.S., Yuen K.Y., Avian influenza virus infections in humans, Chest, 129, pp. 156-168, (2006)
[2]  
Kida H., Webster R.G., Yanagawa R., Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus, Arch Virol, 76, pp. 91-99, (1983)
[3]  
Yoden S., Kida H., Kuwabara M., Yanagawa R., Webster R.G., Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody, Virus Res, 4, pp. 251-261, (1986)
[4]  
Qiu M., Fang F., Chen Y., Wang H., Chen Q., Et al., Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice, Biochem Biophys Res Commun, 343, pp. 1124-1131, (2006)
[5]  
Johansson B.E., Bucher D.J., Kilbourne E.D., Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection, J Virol, 63, pp. 1239-1246, (1989)
[6]  
Johansson B.E., Grajower B., Kilbourne E.D., Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice, Vaccine, 11, pp. 1037-1039, (1993)
[7]  
Chen Z., Kadowaki S., Hagiwara Y., Yoshikawa T., Matsuo K., Et al., Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase, Vaccine, 18, pp. 3214-3222, (2000)
[8]  
Johansson B.E., Moran T.M., Kilbourne E.D., Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins, Proc Natl Acad Sci U S A, 84, pp. 6869-6873, (1987)
[9]  
Powers D.C., Kilbourne E.D., Johansson B.E., Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults, Clin Diagn Lab Immunol, 3, pp. 511-516, (1996)
[10]  
Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G., A DNA transfection system for generation of influenza A virus from eight plasmids, Proc Natl Acad Sci U S A, 97, pp. 6108-6113, (2000)